Effectiveness of Myofascial Release Versus Manual Lymphatic Drainage After Breast Cancer Surgery (MRvsMLD)
Fibromyalgia
About this trial
This is an interventional treatment trial for Fibromyalgia focused on measuring Myofascial-reléase, Fibromyalgia, Lymphatic drainage, Breast cancer
Eligibility Criteria
Inclusion Criteria:
- Women between the ages of 30 and 60 diagnosed with breast cancer undergoing conservative / partial surgery.
- Without lymphedema or mild lymphedema.
- They must have finished the coadjuvant treatment.
Exclusion Criteria:
- Women with muscle or tendon lesions in the arm.
- Kin disorders or circulatory pathology.
- Chemotherapy or radiotherapy.
- Surgical history in the area are excluded from the study.
Sites / Locations
- Gemma Victoria Espí López
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Miofascial-reléase
Manual Lymphatic Drainage (MLD)
Myofascial Release (MR), with the purpose of releasing fascial restriction zones and major fibrosis (thoraco-brachial) caused by restriction after CM tto. IM therapy was applied to the affected area. The position of the patient was identical during both treatment sessions.
It was applied following the Leduc method with the patient in a supine position with 30º elevation of the arm and very superficial and smooth maneuvers were performed in the axillary lymph nodes, in the chest region and in the arm with the same sequence as Guerero et al. The objective of the application in our study is to obtain a beneficial treatment for the patient since it produces an increase of blood and lymphatic circulation, with positive effects on the peripheral vegetative nervous system.